I am/have/had
I am looking for
Advanced Filters
Found 751 clinical trials
Jaktinib Hydrochloride for the Treatment of Ruxolitinib Intolerance of Myelofibrosis
This phase IIB, open-label, multicenter study evaluated the efficacy and safety of oral Jaktinib Dihydrochloride in Intermediate-risk and High-risk Myelofibrosis and Previously Treated With Ruxolitinib
red blood cell transfusion
iron
ruxolitinib
hepatosplenomegaly
myeloproliferative disorder
- 0 views
- 19 Feb, 2024